BioPharma Resources

Drug Trial Radar · NCT04313244

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

A Phase 3, Open-Label, Randomized Trial to Investigate the Immunogenicity and Safety of the Co-administration of a Subcutaneous Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and an Intramuscular Recombinant 9-Valent Human Papillomavirus (9vHPV) Vaccine in Subjects Aged ≥9 to <15 Years in an Endemic Country for Dengue

Last checked: Nov 19, 2026Latest source record: Feb 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 614 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

614

Actual

Start

May 15, 2021

Primary completion

Feb 21, 2022

Study completion Jul 19, 2022

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Mar 18, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 9 years, up to 14 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to demonstrate the non-inferiority (NI) of the immune response to 2 doses of 9vHPV vaccine, 1 co-administered with TDV, compared with 2 doses of 9vHPV vaccine administered alone.

Conditions

  • Dengue Fever

Interventions

  • 9vHPV VaccineBiological

    9vHPV intramuscular injection

  • Dengue Tetravalent Vaccine (TDV)Biological

    TDV subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Geometric Mean Titers (GMTs) for Human Papillomavirus (HPV) Types 6, 11, 16, 18, 31, 33, 45, 52, 58Time frame: Day 210 (Month 7)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • King Chulalongkorn Memorial Hospital

    Bangkok, Thailand

  • The Hospital for Tropical Diseases

    Bangkok, Thailand

  • Thammasat University Hospital

    Pathum Thani, Thailand

  • Siriraj Hospital

    Bangkoknoi, Khet Bangkok Noi, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.